TransCanna Holdings Inc. (CSE:TCAN, XETR:TH8) (“TransCanna” or the “Company”) is pleased to announce the appointment of Mr. Steve Gilblin as President & CEO. Mr. Giblin will also continue as an Executive Director. Mr. Arni Johannson will remain as Chairman of the Board. The company would like to thank former CEO Mr. Jim Pakulis for his efforts launching TransCanna and establishing multiple strategic relationships.

Mr. Giblin has led the rapid growth of multiple companies in Europe, Canada and the United States. With his former company Silverbirch Hotels and Resorts the assets and revenues doubled during his tenure as CEO and he led the successful completion of a billion-dollar sales process. He has worked closely with other industry leading brands with C-suite relationships that include Marriott, Hilton, Bentall Kennedy, Great West Life.

“Significant effort has been made in the past few months to ensure TransCanna has the right strategies and fiscal plan to give the company a solid platform for growth. We have seen a complete team effort with incredible synergies coming together, full thanks to every team member from Santa Cruz, Modesto and our Canadian Public entity” commented Steve Giblin, President & CEO.

Soldaze Acquisition Update

When the transaction closes in mid-September SolDaze will be launching several new SKU’s that will include Spicy Mango, Sour Apple Mango and several other CBD Options. “SolDaze is excited to start our marketing campaign with customer appreciation/education events happening daily throughout California. New flavors will include dragon fruit, blueberries and an on slot of super nutrient vegan/gluten free ingredients. We look forward to continuing to pioneer bringing healthy edibles to the market” Stated Shawn Shevlin Soldaze co-Founder. Since signing the definitive agreement (announced on August 14, 2019) the SolDaze team has successfully produced 2,500 bags of Soldaze products in it’s first two weeks under the TransCanna banner.

Lyfted Farms Acquisition Update

The Company continues to work on the closing of Lyfted Farms Inc. (announced May 20th, 2019). Developments are proceeding exceedingly well, shareholders can anticipate news in the coming days as soon as a material agreement has been reached. Lyfted Farms and their management team have begun working through the onboarding process to develop synergies within TransCanna.

Manufacturing and Distribution

The company has completed an analysis and timeline for the build out of its Daly facility in Modesto. “We are working with the best contractor in the industry to develop our build out plan. We will be prepared to complete the build out as we receive approval on the licenses that have been submitted. The completed facility will give the company the capacity to increase our production to meet market demands for all of our brands” – stated Alan Applonie, General Manager of the Daly facility.

The company is also evaluating alternative southern California distribution locations. “The Adelanto facility has some advantages, but we feel at this time a location closer to the Los Angeles market would serve the company better” said Steve Giblin President and CEO.

IT Infrastructure

After an analysis of several new cannabis focused software solutions available in the market, TransCanna has opted to pause development of it’s 420 Global software in favour of a lower cost “off the shelf” solution that would be immediately available for use. “Being that the company’s growth and operations are progressing ahead of schedule this new approach to our technology will allow us to continue to scale in an cost effective, systematic and compliant manner”. stated Steve Giblin President and CEO.

GoodFellas Group Update

The company had previously announced on July 8, 2019 that it had signed a definitive acquisition agreement with the Goodfellas group. Though the two companies continue to work together to bring a number of Goodfellas brands (Simple Farms and Daily) to market the acquisition agreement is still under negotiation and is not signed at this time. We anticipate a definitive agreement to be signed by the end of September.

Strategic Plan

“With the development of our key asset, the Daly facility in Modesto, and the pending acquisitions of multiple companies and brands the TransCanna team is executing on its’ strategy and poised for rapid growth. We are in negotiations with additional potential acquisitions that will further enhance our suite of products and add to the depth of the management team. The board looks forward to working closely with our new CEO and management to execute on our strategy” Arni Johannson Board Chair.

Top 4 KEY Take away for shareholders

  1. Management is unified and focused
  2. Company is focused on building the business in and then out of Modesto
  3. Management is executing on its diversification with Multi-Brand Approach
  4. Strong vertical integration from upper supply chain through to the end consumer

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian based company providing branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace.

For further information, please visit the Company’s website at or email the Company at

On behalf of the Board of Directors

The information in this news release includes certain information and statements about management’s view of future events, expectations, plans and prospects that constitute forward looking statements. These statements are based upon assumptions that are subject to significant risks and uncertainties. Because of these risks and uncertainties and as a result of a variety of factors, the actual results, expectations, achievements or performance may differ materially from those anticipated and indicated by these forward looking statements. Forward-looking statements in this news release include, but are not limited to: timing of the completion of the SPA and the satisfaction of closing conditions, and the expected benefits of SolDaze to the Company’s business. Any number of factors could cause actual results to differ materially from these forward-looking statements as well as future results. Although the Company believes that the expectations reflected in forward looking statements are reasonable, it can give no assurances that the expectations of any forward looking statements will prove to be correct. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward looking statements to reflect actual results, whether as a result of new information, future events, changes in assumptions, changes in factors affecting such forward looking statements or otherwise.

Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Click here to connect with Transcanna Holdings Inc. (CSE:TCAN) for an Investor Presentation.


Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less